Have been wondering if our B-OM trial and Brilacidin trials as a whole have been under the radar to the medical arena to date or has Dr. Farraye spread the word to the IBD crowd as to Brilacidin's possible cures? I hope the medical community has some knowledge of B but IMO they are busy enough without wasting time on drugs that are still in trials to consider such things.
What brought this up was someone thinking the PR yesterday was a veiled plea from IPIX to the IBD crowd to let the FDA know not to put undue cost and rigours on B (as is seen by their large P3 requirement on ABSSSI that is going to run the cost up to $30MM).
What brought this up was someone thinking the PR yesterday was a veiled plea from IPIX to the IBD crowd to let the FDA know not to put undue cost and rigours on B (as is seen by their large P3 requirement on ABSSSI that is going to run the cost up to $30MM).